Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir

Among different pathogens, opportunistic viral infection caused by EBV is particularly relevant. This gammaherpesvirus, belonging to the Herpesviridae family, may complicate the disease course in different clinical settings by inducing pathological EBV pictures in patients with a defective immunolog...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Caterina Foti, Elvira Favoino, Maria Scarasciulli, Anna Maria Colacicco, Hamidreza Jahantigh, Angela Stufano, Piero Lovreglio, Paola Mascia, Chiara Barlusconi, Federico Perosa, Paolo Romita, Agata Calvario
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/590131e0b4464b74b899bbfe4ad66ccb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:590131e0b4464b74b899bbfe4ad66ccb
record_format dspace
spelling oai:doaj.org-article:590131e0b4464b74b899bbfe4ad66ccb2021-11-20T05:06:13ZChronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir2214-250910.1016/j.idcr.2021.e01331https://doaj.org/article/590131e0b4464b74b899bbfe4ad66ccb2021-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2214250921002870https://doaj.org/toc/2214-2509Among different pathogens, opportunistic viral infection caused by EBV is particularly relevant. This gammaherpesvirus, belonging to the Herpesviridae family, may complicate the disease course in different clinical settings by inducing pathological EBV pictures in patients with a defective immunologic response. Our report evaluated EBV-specific T cell responses by IFN- γ ELISPOT assay, which revealed defective EBV specific immunological response.Caterina FotiElvira FavoinoMaria ScarasciulliAnna Maria ColaciccoHamidreza JahantighAngela StufanoPiero LovreglioPaola MasciaChiara BarlusconiFederico PerosaPaolo RomitaAgata CalvarioElsevierarticleInfectious and parasitic diseasesRC109-216ENIDCases, Vol 26, Iss , Pp e01331- (2021)
institution DOAJ
collection DOAJ
language EN
topic Infectious and parasitic diseases
RC109-216
spellingShingle Infectious and parasitic diseases
RC109-216
Caterina Foti
Elvira Favoino
Maria Scarasciulli
Anna Maria Colacicco
Hamidreza Jahantigh
Angela Stufano
Piero Lovreglio
Paola Mascia
Chiara Barlusconi
Federico Perosa
Paolo Romita
Agata Calvario
Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir
description Among different pathogens, opportunistic viral infection caused by EBV is particularly relevant. This gammaherpesvirus, belonging to the Herpesviridae family, may complicate the disease course in different clinical settings by inducing pathological EBV pictures in patients with a defective immunologic response. Our report evaluated EBV-specific T cell responses by IFN- γ ELISPOT assay, which revealed defective EBV specific immunological response.
format article
author Caterina Foti
Elvira Favoino
Maria Scarasciulli
Anna Maria Colacicco
Hamidreza Jahantigh
Angela Stufano
Piero Lovreglio
Paola Mascia
Chiara Barlusconi
Federico Perosa
Paolo Romita
Agata Calvario
author_facet Caterina Foti
Elvira Favoino
Maria Scarasciulli
Anna Maria Colacicco
Hamidreza Jahantigh
Angela Stufano
Piero Lovreglio
Paola Mascia
Chiara Barlusconi
Federico Perosa
Paolo Romita
Agata Calvario
author_sort Caterina Foti
title Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir
title_short Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir
title_full Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir
title_fullStr Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir
title_full_unstemmed Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir
title_sort chronic-relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced ebv-specific t cell response using enzyme-linked immunospot (elispot) assay successfully treated with valaciclovir
publisher Elsevier
publishDate 2021
url https://doaj.org/article/590131e0b4464b74b899bbfe4ad66ccb
work_keys_str_mv AT caterinafoti chronicrelapsingcutaneousleukocytoclasticvasculitisinayoungpatientwithreducedebvspecifictcellresponseusingenzymelinkedimmunospotelispotassaysuccessfullytreatedwithvalaciclovir
AT elvirafavoino chronicrelapsingcutaneousleukocytoclasticvasculitisinayoungpatientwithreducedebvspecifictcellresponseusingenzymelinkedimmunospotelispotassaysuccessfullytreatedwithvalaciclovir
AT mariascarasciulli chronicrelapsingcutaneousleukocytoclasticvasculitisinayoungpatientwithreducedebvspecifictcellresponseusingenzymelinkedimmunospotelispotassaysuccessfullytreatedwithvalaciclovir
AT annamariacolacicco chronicrelapsingcutaneousleukocytoclasticvasculitisinayoungpatientwithreducedebvspecifictcellresponseusingenzymelinkedimmunospotelispotassaysuccessfullytreatedwithvalaciclovir
AT hamidrezajahantigh chronicrelapsingcutaneousleukocytoclasticvasculitisinayoungpatientwithreducedebvspecifictcellresponseusingenzymelinkedimmunospotelispotassaysuccessfullytreatedwithvalaciclovir
AT angelastufano chronicrelapsingcutaneousleukocytoclasticvasculitisinayoungpatientwithreducedebvspecifictcellresponseusingenzymelinkedimmunospotelispotassaysuccessfullytreatedwithvalaciclovir
AT pierolovreglio chronicrelapsingcutaneousleukocytoclasticvasculitisinayoungpatientwithreducedebvspecifictcellresponseusingenzymelinkedimmunospotelispotassaysuccessfullytreatedwithvalaciclovir
AT paolamascia chronicrelapsingcutaneousleukocytoclasticvasculitisinayoungpatientwithreducedebvspecifictcellresponseusingenzymelinkedimmunospotelispotassaysuccessfullytreatedwithvalaciclovir
AT chiarabarlusconi chronicrelapsingcutaneousleukocytoclasticvasculitisinayoungpatientwithreducedebvspecifictcellresponseusingenzymelinkedimmunospotelispotassaysuccessfullytreatedwithvalaciclovir
AT federicoperosa chronicrelapsingcutaneousleukocytoclasticvasculitisinayoungpatientwithreducedebvspecifictcellresponseusingenzymelinkedimmunospotelispotassaysuccessfullytreatedwithvalaciclovir
AT paoloromita chronicrelapsingcutaneousleukocytoclasticvasculitisinayoungpatientwithreducedebvspecifictcellresponseusingenzymelinkedimmunospotelispotassaysuccessfullytreatedwithvalaciclovir
AT agatacalvario chronicrelapsingcutaneousleukocytoclasticvasculitisinayoungpatientwithreducedebvspecifictcellresponseusingenzymelinkedimmunospotelispotassaysuccessfullytreatedwithvalaciclovir
_version_ 1718419597968801792